Sano Genetics Raises $11.4M in Funding
Summary
Sano Genetics, a Cambridge, UK-based provider of a software platform for precision medicine clinical trials, raised $11.4M in funding. Founded by Patrick Short (CEO), Charlotte Guzzo (COO) and William Jones (CTO), Sano Genetics is developing software to enable precision medicine. It combines genetic testing, recruitment, and long-term engagement in one platform, accelerating enrollment and simplifying operations for precision medicine teams and patients. In the past 12 months, we’ve scaled up our capacity to hold three times more trials than the year before and launched our first programme supporting families affected by ALS. I’m so pleased with everything the team has achieved so far and this new funding will help us to integrate LLMs and other AI tools to drive more productivity.